BMX and nonpapillary renal cell carcinoma: To further investigate whether TRIM26 inhibited cell malignant behaviors depending on ETK-mediated inactivation of mTOR signaling pathway, we altered the expression levels of ETK and TRIM26 in ccRCC cells at the same time and examined their impact on malignant behavior.